Miscellaneous
Non-alcoholic fatty liver disease (NAFLD) a condition where disruptions and dysregulation of lipids in the body causes an excessive build-up of fat in the liver, and is estimated to affect 75% of people with type 2 diabetes. In around 1/5 of cases this steatosis causes chronic inflammation, which can lead to fibrosis, cirrhosis and hepatocellular carcinoma. So what do people with diabetes need to know, and how do we raise awareness? We’re joined by Prof. William Alazawi to discuss these questions. References: Marjot T, et al. Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management. Endocr Rev. 2020 Jan 1;41(1):bnz009. doi: 10.1210/endrev/bnz009. Disclosures: Prof William Alazawi declares no relevant conflicts of interest. This independent educational activity is supported by an educational grant from Novo Nordisk A/S. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Novo Nordisk A/S has had no influence on the content of this education.